Vernon Rowe

1.7k total citations
24 papers, 424 citations indexed

About

Vernon Rowe is a scholar working on Physiology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Vernon Rowe has authored 24 papers receiving a total of 424 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Vernon Rowe's work include Connective tissue disorders research (3 papers), Obstructive Sleep Apnea Research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Vernon Rowe is often cited by papers focused on Connective tissue disorders research (3 papers), Obstructive Sleep Apnea Research (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Vernon Rowe collaborates with scholars based in United States, Hungary and Cameroon. Vernon Rowe's co-authors include Gordon Guroff, Arnold E. Andersen, Jean Schoenen, Deena E. Kuruvilla, Denise E. Chou, John J. Kepes, Elizabeth S. Rowe, Ralph H. B. Benedict, Peter Zarevics and E. A. Neale and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neurology and Journal of Neurochemistry.

In The Last Decade

Vernon Rowe

24 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vernon Rowe United States 12 112 107 100 96 78 24 424
Ameneh Zare-Shahabadi Iran 10 151 1.3× 33 0.3× 128 1.3× 123 1.3× 65 0.8× 20 567
Marius Krauthausen Germany 11 166 1.5× 78 0.7× 56 0.6× 308 3.2× 71 0.9× 13 782
Melissa Cosenza-Nashat United States 7 148 1.3× 51 0.5× 53 0.5× 124 1.3× 108 1.4× 7 596
Sirpa Rainesalo Finland 14 93 0.8× 33 0.3× 365 3.6× 75 0.8× 250 3.2× 31 637
Elizabeth Walker New Zealand 10 303 2.7× 19 0.2× 109 1.1× 142 1.5× 344 4.4× 22 667
Terry Rd United States 8 228 2.0× 61 0.6× 42 0.4× 220 2.3× 178 2.3× 17 710
Miguel A. Riudavets United States 12 132 1.2× 22 0.2× 116 1.2× 293 3.1× 64 0.8× 16 522
William Au United States 5 159 1.4× 13 0.1× 75 0.8× 178 1.9× 52 0.7× 7 490
Aswini Gnanasekaran United States 6 220 2.0× 16 0.1× 31 0.3× 86 0.9× 110 1.4× 7 390
Verónica Murta Argentina 10 92 0.8× 29 0.3× 26 0.3× 39 0.4× 56 0.7× 12 364

Countries citing papers authored by Vernon Rowe

Since Specialization
Citations

This map shows the geographic impact of Vernon Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vernon Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vernon Rowe more than expected).

Fields of papers citing papers by Vernon Rowe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vernon Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vernon Rowe. The network helps show where Vernon Rowe may publish in the future.

Co-authorship network of co-authors of Vernon Rowe

This figure shows the co-authorship network connecting the top 25 collaborators of Vernon Rowe. A scholar is included among the top collaborators of Vernon Rowe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vernon Rowe. Vernon Rowe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rowe, Elizabeth S., et al.. (2021). A nephroprotective iodinated contrast agent with cardioprotective properties: A pilot study. Journal of Neuroimaging. 31(4). 706–713. 4 indexed citations
2.
Frohman, Elliot M., Nicole R. Villemarette-Pittman, Reid Longmuir, et al.. (2020). Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced ‘PANIC’ attack. Journal of the Neurological Sciences. 415. 116935–116935. 29 indexed citations
3.
Chou, Denise E., et al.. (2018). Acute migraine therapy with external trigeminal neurostimulation (ACME): A randomized controlled trial. Cephalalgia. 39(1). 3–14. 110 indexed citations
5.
Rowe, Vernon, et al.. (2017). 0449 EVALUATION OF SLEEP DISORDERED BREATHING IN HYPERMOBILE PATIENTS. SLEEP. 40(suppl_1). A167–A167. 1 indexed citations
6.
Beh, Shin C., Eric Kildebeck, Ram Narayan, et al.. (2016). High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes. Journal of the Neurological Sciences. 372. 187–195. 14 indexed citations
7.
Rowe, Elizabeth S., et al.. (2016). Preclinical Studies of a Kidney Safe Iodinated Contrast Agent. Journal of Neuroimaging. 26(5). 511–518. 13 indexed citations
8.
Hutchinson, Michael, Elizabeth S. Rowe, Michael Kushner, & Vernon Rowe. (2013). Appropriate Use of Advanced Imaging Services by Providers Who Self‐Refer is Saving Medicare Billions. Journal of Neuroimaging. 23(1). 159–161. 1 indexed citations
9.
Benedict, Ralph H. B., F Munschauer, Peter Zarevics, et al.. (2008). Effects of l-amphetamine sulfate on cognitive function in multiple sclerosis patients. Journal of Neurology. 255(6). 848–852. 38 indexed citations
10.
Rowe, Vernon. (2001). PHOSPHORUS REMOVAL TECHNIQUES IN POULTRY WASTEWATER. Proceedings of the Water Environment Federation. 2001(12). 26–30. 3 indexed citations
11.
Lin, James T., Vernon Rowe, Steven W. Brostoff, & Nabih I. Abdou. (1982). Lymphocyte studies in a patient with chronic polyradiculoneuropathy. Neurology. 32(10). 1127–1127. 10 indexed citations
12.
Rowe, Vernon, et al.. (1981). Developmental changes in the stimulation of serotonin N-acetyltransferase activity and melatonin synthesis in the rat pineal in monolayer culture.. Journal of Pharmacology and Experimental Therapeutics. 218(1). 97–102. 13 indexed citations
13.
Rowe, Vernon, et al.. (1981). Effects of norepinephrine and dibutyryl adenosine 3?, 5?-cyclic monophosphate on the ultrastructure of pineal cells in monolayer culture. Cell and Tissue Research. 216(1). 181–91. 13 indexed citations
14.
Rowe, Vernon, et al.. (1981). Morphologic development of neonatal rat pinealocytes in monolayer culture. Cell and Tissue Research. 220(2). 11 indexed citations
15.
Rowe, Vernon, et al.. (1980). Pineal cells enhance choline acetyltransferase activity in sympathetic neurons. Journal of Neurobiology. 11(6). 547–556. 9 indexed citations
16.
Rowe, Vernon, et al.. (1980). Cockayne syndrome. Neurology. 30(12). 1268–1268. 28 indexed citations
17.
Yu, Meng-Lin, et al.. (1977). NERVE GROWTH FACTOR AND THE ACTIVITY OF TYROSINE HYDROXYLASE IN ORGAN CULTURES OF RAT SUPERIOR CERVICAL GANGLIA. Journal of Neurochemistry. 28(4). 835–842. 22 indexed citations
18.
Rowe, Vernon, et al.. (1977). Pineal gland cells in culture. Experimental Cell Research. 104(2). 345–356. 27 indexed citations
19.
Rowe, Vernon, Henry M. Fales, John J. Pisano, Arnold E. Andersen, & Gordon Guroff. (1975). Urinary metabolites of phenylalanine in the preweanling rat treated with p-chlorophenylalanine and phenylalanine. Biochemical Medicine. 12(2). 123–136. 7 indexed citations
20.
Rowe, Vernon, et al.. (1973). Some characteristics of the p-chlorophenylalanine-induced cataract. Experimental Eye Research. 17(3). 245–250. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026